Alnylam Pharmaceuticals (ALNY) PT Raised to $86 at Jefferies
Jefferies analyst Gena Wang reiterated a Buy rating and raised her price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) ti $86.00 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)